CPSA BRASIL 2015

On The Way to Innovation: Pharmaceutical/Analytical Technology, Regulation and Knowledge Management

Preliminary Program Agenda

Updated February 26, 2015

Tuesday 4 August


Registration & Continental Breakfast


Welcome & Opening Remarks

Mike Lee

Welcome
Mike S. Lee
Milestone Development Services

Rafael Barrientos

Format, Objectives, Opening Remarks
Rafael Barrientos
Eurofarma Laboratórios S.A.


Plenary Lecture

Nathan Yates

A Global Overview on Biomarkers, Large Molecules and Proteomics
Nathan A. Yates Bio
University of Pittsburgh


Symposium Session

Fixed Drug Combination (FDC): BA/BE, Pharmaceutical Equivalence and Regulatory Updates
Chair: Mauricio Magalhães, EMS


Sponsored Lunch & Roundtable Event


Symposium Session

Clinical Assays in Brazil: Regulatory Updates and Challenges
Chair: Carlos Kiffer - GC2

Pharmaceutical Industry Perspective
Debora Garcia Rodrigues, Cristália

Class Association Perspective
Vitor Harada, Quintiles

CRO Perspective
José Emílio S. Neto, Icon Clinical Research


Symposium Session

New Drug Release and Process Technologies: An Overview
Chair: Gabriel Araújo, University of São Paulo

Wednesday 5 August


Registration & Continental Breakfast



Symposium Session

Biossimilars: Where Are We and Where Are We Going?
Chair: Vanda Magalhaes, Eurofarma


Sponsored Lunch & Roundtable Event


Symposium Session

Drug Discovery: Are We Prepared for That?
Chair: Gabriela Barreiro, Eurofarma


Symposium Session

Personalize Medicine with Better Diagnoses, Better Treatment Through Innovative Analytical Methods
Co-Chairs: Daniel Lebre, CEMSA and Dulce Casarini, UNIFESP


Wrap Up & Adjourn
Rafael Barrientos, Eurofarma Laboratórios S.A and Mike Lee, Milestone Development Services